Drug Profile
Bioconjugate pneumococcal vaccine - LimmaTech Biologics
Alternative Names: Pneumo1; Pneumococcal-vaccine-Limmatech-BiologicsLatest Information Update: 28 Oct 2020
Price :
$50
*
At a glance
- Originator LimmaTech Biologics
- Class Pneumococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Pneumococcal infections
Most Recent Events
- 28 Oct 2020 No recent reports of development identified for phase-I development in Pneumococcal-infections in Germany (IM, Injection)
- 12 Sep 2018 LimmaTech Biologics AG completes a phase I trial in Pneumococcal infections in Germany (IM) (NCT03303976)
- 07 Sep 2017 Phase-I clinical trials in Pneumococcal infections in Germany (IM) (NCT03303976)